RECOVERY:This is a special public notice that contract HHSN261200522002C was modified to award American Reinvestment and Recovery Act (ARRA) funds. THIS NOTICE IS NOT A SOLICITATION FOR OFFERS OR BIDS.

The contract HHSN261200522002C was modified to award funds from the American Reinvestment and Recovery Act (ARRA) for a project titled "RECOVERY: In Vitro Screening of Combinations of Chemotherapy Drugs." The modification, identified as modification 16, reflects a competitive procurement conducted under a cost reimbursement type contract. This approach was chosen due to the inherent difficulty in precising project specifications and accurately estimating costs, making a fixed-price contract unsuitable. The total award amount for this modification is $886,790, and the contractor is the University of Pittsburgh. The contract ensures that adequate safeguards are in place to guarantee that all costs charged are allowable, allocable, fair, and reasonable. This contract, initiated on September 19, 2010, supports research efforts involving the screening of chemotherapy drug combinations in vitro. Administrative details include the contracting officer, Stanley A. Knight, reachable via provided contact information, and the contract falls under NAICS code 541711, which pertains to research and development in the physical, engineering, and life sciences. This notice serves as an update on the contract modification and is not a solicitation for further offers or bids.